Sector | Trading | Compare with Sector peers |
Industry | Trading | Compare with Industry peers |
Website | http://www.riddhisiddhi.co.in | |
Market Cap | 359.52 Cr. | |
Enterprise Value(EV) | 468.55 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -60.27 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 64.37 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 2,118.78 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.24 | Calculated using Price: 504.25 |
Dividend Yield | 0.30 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.71 Cr. | 7,129,786 Shares |
FaceValue | 10 | |
About Riddhi Siddhi Gluco Biols Ltd. | ||
Riddhi Siddhi Gluco Biols is the one of innovation and adventure, of risks taken and bold decisions made. The seeds of this successful corporate conglomerate were sown in 1990 in the name of Riddhi Siddhi Chemicals Pvt Ltd. In March 1992 the name was changed to Riddhi Siddhi Chemicals Ltd. What followed was an unmatched series of innovations, achievements and accolades. |
1 Day |
|
-0.19% |
1 Week |
|
-3.18% |
1 Month |
|
-13.51% |
3 Month |
|
+12.08% |
6 Month |
|
+11.62% |
1 Year |
|
+50.88% |
2 Year |
|
+43.89% |
5 Year |
|
+59.98% |
10 Year |
|
+141.38% |
8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 3.21 | -3.37 | 0.65 | 4.76 | 1.68 | -4.3 | 3.29 | 2.27 | |
Return on Capital Employed (%) | 5.08 | 1.64 | 1.64 | 6.17 | 3.53 | 0.47 | 4.3 | 3.53 | |
Return on Assets (%) | 2.12 | -2.04 | 0.39 | 3.2 | 1.2 | -3.17 | 2.58 | 1.89 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1,367 | 1,323 | 1,389 | 1,436 | 1,425 | 1,453 | 1,504 | 1,432 | 1,502 | |
Non Curr. Liab. | 254 | 232 | 169 | 108 | 61 | 96 | 90 | 13 | 12 | |
Curr. Liab. | 347 | 640 | 416 | 357 | 340 | 292 | 156 | 96 | 215 | |
Minority Int. | 107 | 178 | 168 | 165 | 133 | 99 | 87 | 58 | 57 | |
Equity & Liab. | 2,075 | 2,373 | 2,142 | 2,066 | 1,959 | 1,941 | 1,838 | 1,692 | 1,785 | |
Non Curr. Assets | 952 | 1,026 | 1,072 | 1,131 | 976 | 1,341 | 1,298 | 965 | 1,000 | |
Curr. Assets | 1,123 | 1,347 | 1,070 | 935 | 983 | 600 | 539 | 490 | 785 | |
Misc. Exp. not W/O | ||||||||||
Total Assets | 2,075 | 2,373 | 2,142 | 2,066 | 1,959 | 1,941 | 1,838 | 1,692 | 1,785 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 342 | 508 | 804 | 682 | 576 | 498 | 223 | 173 | 288 | |
Other Income | 134 | 118 | 335 | 70 | 50 | 59 | 62 | 68 | 81 | |
Total Income | 476 | 626 | 1,139 | 752 | 627 | 557 | 285 | 241 | 369 | |
Total Expenditure | -349 | -560 | -1,073 | -605 | -529 | -511 | -200 | -173 | -285 | |
PBIDT | 127 | 66 | 66 | 147 | 98 | 45 | 85 | 68 | 84 | |
Interest | -33 | -52 | -62 | -40 | -31 | -26 | -8 | -8 | -9 | |
Depreciation | -35 | -35 | -34 | -35 | -37 | -37 | -13 | -12 | -11 | |
Taxation | -15 | -25 | 39 | -6 | -6 | -44 | -16 | -15 | -26 | |
Exceptional Items | ||||||||||
PAT | 44 | -45 | 9 | 67 | 24 | -62 | 49 | 33 | 38 | |
Minority Interest | -4 | 3 | 10 | -19 | 9 | 15 | 12 | 29 | 27 | |
Share Associate | ||||||||||
Other Related Items | ||||||||||
Consolidated Net Profit | 40 | -43 | 19 | 49 | 33 | -47 | 14 | -56 | -43 | |
Adjusted EPS | 56 | -60 | 27 | 68 | 46 | -66 | 20 | -78 | -60 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -284 | -34 | -1 | 116 | 130 | 161 | 1 | |
Cash Fr. Inv. | -67 | 65 | 269 | 163 | 30 | -91 | -71 | 8 | |
Cash Fr. Finan. | -55 | 192 | -263 | -169 | -131 | -108 | -94 | 2 | |
Net Change | -122 | -27 | -28 | -7 | 15 | -69 | -3 | 11 | |
Cash & Cash Eqvt | 2 | 4 | 1 | 1 | 32 | 3 | 0 | 11 |
Sat, 10 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting Of Riddhi Siddhi Gluco Biols Limited ("Company") Held On Saturday 10Th February 2024 Pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 ("Listing Regulations") we hereby submit outcome of meeting of Board of Directors of Company held on Saturday 10th February 2024. |
Sat, 10 Feb 2024
Results - Financial Results For December 2023 (Standalone And Consolidated) Pursuant to regulation 30 & 33 of SEBI(LODR) Regulations 2015 We hereby submit unaudited standalone & consolidated financial results of the Company for the quarter and nine months ended on 31st December 2023. |
Sat, 03 Feb 2024
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Finacial Results Fot The Quarter And Nine Months Ended 31.12.2023. RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Approval of unaudited standalone and consolidated finacial results fot the quarter and nine months ended 31.12.2023. |
Thu, 28 Mar 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Opening at High |
Close Below Last Month Low |